Decibel Cannabis Company Inc. announced that it has expanded its global footprint by entering into a supply agreement (the "Agreement") to provide premium dried medical cannabis flower to 4C LABS, a healthcare, technology, and pharmaceutical company focused on virtual prescribing, pharmaceutical distribution and clinical development in cannabis based medicinal products for human h ealth in the United Kingdom and Channel Islands (the "UK"). Decibel to supply 4C LABS with Qwest branded, craft-quality Medical Cannabis for distribution to UK medical cannabis patients; Decibel to grant strain exclusivity of rare and unique cultivars to be distributed by 4C LABS; 3-year supply agreement; Initial shipment expected before year end; Minimum purchase commitments achieve exclusivity over certain genetics and QWEST brand in the UK.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 CAD | 0.00% | +4.35% | -7.69% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.69% | 35.93M | |
+40.09% | 6.16B | |
-16.34% | 4.46B | |
-7.11% | 3.27B | |
+5.14% | 3.2B | |
-0.18% | 2.6B | |
+47.93% | 1.98B | |
-7.15% | 1.7B | |
+0.67% | 1.66B | |
-8.73% | 1.61B |
- Stock Market
- Equities
- DB Stock
- News Decibel Cannabis Company Inc.
- Decibel Cannabis Company Inc. Expands Global Footprint with Agreement to Supply Medical Cannabis to 4C Labs for Distribution in the United Kingdom